share_log

安科生物(300009.SZ):利用基因重组技术开发了人生长激素注射液、人干扰素注射液、注射用曲妥珠单抗等多款药物

Anke Biotech (300009.SZ): Using genetic recombination technology, it has developed various drugs such as human growth hormone injections, human interferon injections, and trastuzumab for injections

Gelonghui Finance ·  May 8 05:09

Gelonghui, May 8, 丨 Anke Biology (300009.SZ) said on the investor interactive platform that synthetic biology comprehensive genetic engineering, bioengineering, chemical synthesis and computer simulation technologies can be applied to various fields such as medicine, chemicals, agriculture, environment, etc. Our company has been deeply involved in the biopharmaceutical field for many years, and has used genetic recombination technology to develop various drugs such as human growth hormone injections, human interferon injections, and trastuzumab for injections, and actively use computer simulation and other technologies to assist in the development of new products. and the layout of the new pipeline.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment